From the Newsroom| Fourth Ranbaxy plant under FDA scrutiny
2018-02-16
2
Mint's CH Unnikrishnan talks about the trouble drug maker Ranbaxy is facing with the US regulator.
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
Dinesh Thakur on Ranbaxy US FDA case
Ranbaxy accused of gaming FDA rules to thwart rival drug makers
Food at Siddhivinayak, Tirupati temples to come under regulator's scrutiny
More than 300,000 Volkswagen cars under scrutiny in India
Title: From the Newsroom: Violence at Maruti's Manesar plant
From the Newsroom | L&T to sell thermal plant in Punjab
From the newsroom: Tata Capital to bring insurance, AMC firms under its fold
From the Newsroom: Banks will lend to students under management quota
From the newsroom: Private-equity
From the Newsroom: Costly fertilizers
